Salivary Gland Inflammation (Sialadenitis): Drug Therapy

Therapeutic targets

  • In case of bacterial infection: cure.
  • Pain relief
  • Relief of xerostomia (dry mouth)

Therapy recommendations

  • Symptomatic therapy
  • Antibiosis – for bacterial infection.
    • Indications:
      • Acute bacterial sialadenitis
      • Postoperative parotitis (parotid gland inflammation).
      • Chronic recurrent parotitis in the acute interval.
      • Chronic recurrent sialadenitis of the submandibular gland in the acute interval
      • Parotitis epidemica (mumps) with involvement of the CNS concomitant with prednisolone administration.
      • Supportive curative to surgical intervention.
      • Propagation tendency
      • Systemic manifestation
      • Endocarditis (endocarditis)-prone patients, regardless of the severity of infection.
      • Risk of exacerbation (marked worsening of the clinical picture) of a general disease.
      • Impaired immune defense (eg, cytostatic or systemic corticosteroid therapy, immunosuppression), regardless of the severity of infection.
      • Postoperative persistent (ongoing) inflammation despite adequate drainage.
  • Sialagoga – Via excitation of the parasympathetic nervous system, they lead to increased saliva production.
  • Saliva substitutes – They are intended to provide long-lasting moistening of the dental hard tissues as well as the oral mucosa.
    • Additional desirable side effects of saliva substitutes include remineralizing potential, antimicrobial action, and relief of xerostomia.
    • Saliva substitutes usually contain a wide variety of base substances as well as additives. Especially proven fluoride-containing mucin-based saliva substitutes with calcium and phosphate.
    • Cave: With saliva substitutes based on carboxymethyl cellulose, there is a risk of demineralization of the dental hard tissue. An addition of calcium, phosphate and / or fluoride ions counteracts this.
  • Glucocorticoids
    • Indications:
      • Chronic recurrent parotitis in the interval.
      • Heerfordt syndrome
      • Parotitis epidemica: with central nervous system involvement (prednisolone under antibiosis).
      • Vasculitic complications of chronic myoepithelial sialadenitis.
  • In the presence of cytomegaly or rheumatic diseases: see under the respective disease.